% Expired Patents = 16.7

EPO Patents = 6

Trademarks = 15

Forward Citations = 104

Loading Chart...

8 inventors (with patents filed for the assignee):

Nicholas D Smith (6 out of 59 patents)

Steven P Govek (6 out of 34 patents)

Mehmet Kahraman (5 out of 34 patents)

4. Johnny Yasuo Nagasawa (5 out of 27 patents)

5. Andiliy Gokching Lai (3 out of 19 patents)

6. Celine Bonnefous (2 out of 12 patents)

7. Jackaline Dalgard Julien (2 out of 12 patents)

8. Karensa L Douglas (1 out of 6 patents)

9. Mark R Herbert (13 patents)

10. Jeffrey H Hager (9 patents)

11. Edna Chow Maneval (8 patents)

12. Jackaline D Julien (0 patent)

6 patents: Sort by Forward Citations

1. 9499538 - Estrogen receptor modulators and uses thereof (2016-11-22),

2. 9193714 - Fluorinated estrogen receptor modulators and uses thereof (2015-11-24),

3. 9187460 - Estrogen receptor modulators and uses thereof (2015-11-17),

4. 9078871 - Estrogen receptor modulators and uses thereof (2015-07-14),

5. 8853423 - Indane estrogen receptor modulators and uses thereof (2014-10-07),

6. 8703810 - Estrogen receptor modulators and uses thereof (2014-04-22),

Seragon Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to developing innovative therapies for complex diseases. With a focus on cutting-edge research and advanced drug development, Seragon strives to improve patient outcomes and quality of life worldwide. With a commitment to scientific excellence and patient-centric approach, Seragon is shaping the future of healthcare.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#762 in San Diego, CA

#10,565 in California

#44,949 in US

San Diego, CA, United States of America

Seragon Pharmaceuticals, Inc.